U.K. allergy drug reclassification
This article was originally published in The Tan Sheet
Galpharm Healthcare requests the Medicines and Healthcare products Regulatory Agency expand the pack size limit of its Galpharm Non-Drowsy Hayfever and Allergy Relief Tablets (loratadine 10 mg tablets) for general sale. The drug currently has general sale status in the U.K. with a maximum pack size of seven tablets, and the firm requests that the agency increase the allowable pack size for general sale to 14 tablets. MHRA published the request on its Web site Aug. 27 and requests comments on the issue by Sept. 25. The drug has been available in the seven-tablet pack for general sale since 2003, and larger packs have been available in pharmacy only sales since 1993
You may also be interested in...
The top-line data in the ultra-rare disease are also the first to demonstrate safety and efficacy of an RNAi therapy in patients six years and younger.
Bayer notes “significant headwinds" from pandemic hitting its 2020 results likely will continue in 2021, when it t expects core earnings per share slightly below 2020 levels. While noting slumping revenues across its divisions, Bayer said an exception its consumer health business.
After US President Trump said vaccine developers could develop a COVID-19 vaccine faster if it weren't for politics, Moderna CEO Bancel said no political party has asked the company to move faster or slower.